Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 ( Br. J. Haematol . 2012; 157: 47–58): use of direct acting oral anticoagulants

(2020) Deepa R. J. Arachchillage et al.   BRITISH JOURNAL OF HAEMATOLOGY

Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte

(2019) O. Sanchez et al.   REVUE DES MALADIES RESPIRATOIRES

Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis

(2019) Maha A. T. Elsebaie et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

EULAR recommendations for the management of antiphospholipid syndrome in adults

(2019) Maria G Tektonidou et al.   ANNALS OF THE RHEUMATIC DISEASES

The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study

(2019) Ali Duarte‐García et al.   Arthritis & Rheumatology

Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis

(2019) Jorge Sanchez-Redondo et al.   CLINICAL THERAPEUTICS

Treatment of the antiphospholipid syndrome with direct oral anticoagulants

(2019) Rupert Bauersachs et al.   Vasa-European Journal of Vascular Medicine

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

(2019) Josep Ordi-Ros et al.   ANNALS OF INTERNAL MEDICINE

The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism

(2019) Stavros V Konstantinides et al.   EUROPEAN HEART JOURNAL

Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort study

(2019) T Sato et al.   LUPUS

Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study

(2019) K Malec et al.   LUPUS

Prevalence of confirmed antiphospholipid syndrome in 18‐50 years unselected patients with first unprovoked venous thromboembolism

(2019) Sebastien Miranda et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism

(2018) Clive Kearon et al.   BLOOD

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

(2018) Vittorio Pengo et al.   BLOOD

Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis

(2018) Virginie Dufrost et al.   AUTOIMMUNITY REVIEWS

Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

(2017) Salma Siddique et al.   Current Rheumatology Reports

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective

(2016) Erin A. Bohula et al.   CIRCULATION

Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH

(2016) A. Tripodi et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™

(2016) Samuel Z Goldhaber et al.   VASCULAR MEDICINE

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

(2016) Hannah Cohen et al.   Lancet Haematology

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

(2015) J. Gebhart et al.   BLOOD

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome

(2015) Scott C. Woller et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

(2014) N. van Es et al.   BLOOD

Guidance, guidelines, and communications

(2014) J. D. Douketis et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome

(2014) Guillaume Canaud et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review

(2013) D. Garcia et al.   BLOOD

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

(2013) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature

(2013) Laura Andreoli et al.   ARTHRITIS CARE & RESEARCH

Guidelines on the investigation and management of antiphospholipid syndrome

(2012) David Keeling et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

(2012) Maarten G. Lansberg et al.   CHEST

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH

(2012) T. BAGLIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

(2011) V. Pengo et al.   BLOOD

Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus

(2011) S. Zuily et al.   CIRCULATION

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

(2011) G Ruiz-Irastorza et al.   LUPUS

Update of the guidelines for lupus anticoagulant detection

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS